Flex Biomedical
Madison · Founded 2007
About Flex Biomedical
Flex Biomedical, a Madison-based company founded in 2007, is developing innovative treatments for orthopedic diseases. The company's lead product, the Flex Polymer™, is a synthetic polymer designed to treat osteoarthritis, an incurable, debilitating joint disease that affects 27 million people in the United States and 100 million people worldwide.
Company Facts
- Founded: 2007
- Legal name: Flex Biomedical, Inc.
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $4.4M
- Last round: Series Unknown (May 2014)
- Website: flexbio.com
- Phone: 608-213-8246
Social Profiles
Canonical: https://fsome.com/organization/flex-biomedical-8253041 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.